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Abstract
Objective: The aim of this paper was to examine the relationship between childhood maltreatment and adult psychopathology, as 
reflected in hypothalamic-pituitary-adrenal axis dysfunction. Method: A selective review of the relevant literature was undertaken in 
order to identify key and illustrative research findings. Results: There is now a substantial body of preclinical and clinical evidence 
derived from a variety of experimental paradigms showing how early-life stress is related to hypothalamic-pituitary-adrenal axis function 
and psychological state in adulthood, and how that relationship can be modulated by other factors. Discussion: The risk for adult 
psychopathology and hypothalamic-pituitary-adrenal axis dysfunction is related to a complex interaction among multiple experiential 
factors, as well as to susceptibility genes that interact with those factors. Although acute hypothalamic-pituitary-adrenal axis responses 
to stress are generally adaptive, excessive responses can lead to deleterious effects. Early-life stress alters hypothalamic-pituitary-adrenal 
axis function and behavior, but the pattern of hypothalamic-pituitary-adrenal dysfunction and psychological outcome in adulthood reflect 
both the characteristics of the stressor and other modifying factors. Conclusion: Research to date has identified multiple determinants 
of the hypothalamic-pituitary-adrenal axis dysfunction seen in adults with a history of childhood maltreatment or other early-life stress. 
Further work is needed to establish whether hypothalamic-pituitary-adrenal axis abnormalities in this context can be used to develop 
risk endophenotypes for psychiatric and physical illnesses.
Descriptors: Cortisol; Risk factor; Psychopathology; Child abuse; Hypothalamus
Resumo
Objetivo: A meta deste artigo foi a de estudar as relações ente maus-tratos na infância e psicopatologia no adulto, como reflexo de uma 
disfunção do eixo hipotálamo-pituitária-adrenal. Método: Uma revisão seletiva da literatura relevante foi feita para identificar achados-
chave e ilustrativos. Resultados: Existe atualmente um volume significativo de achados científicos pré-clínicos e clínicos derivados de 
paradigmas experimentais, que demonstram que o estresse precoce está relacionado à função do eixo hipotálamo-pituitária-adrenal 
e a estados psicológicos no indivíduo adulto, e como esta relação pode ser modulada por outros fatores. Discussão: O risco para o 
desenvolvimento de psicopatologia no adulto e disfunções do eixo hipotálamo-pituitária-adrenal está relacionado à complexa interação 
de múltiplos fatores vivenciais, assim como a genes que levam a uma susceptibilidade, que interagem com estes fatores. Embora as 
respostas agudas do eixo hipotálamo-pituitária-adrenal sejam geralmente adaptativas, as respostas excessivas podem levar a efeitos 
deletérios. O estresse precoce pode alterar a função do eixo hipotálamo-pituitária-adrenal assim como o comportamento, porém, o 
padrão da disfunção do eixo hipotálamo-pituitária-adrenal e a evolução psicológica na vida adulta refletem ambas as características 
do estressor e outros fatores modificadores. Conclusão: A pesquisa atual identificou múltiplos determinantes da disfunção do eixo 
hipotálamo-pituitária-adrenal encontrados em adultos com história de maus-tratos na infância ou outros estressores precoces. Trabalhos 
futuros são necessários para estabelecer se as anormalidades do eixo hipotálamo-pituitária-adrenal neste contexto podem ser usadas 
para o desenvolvimento de endofenótipos de risco para doenças físicas ou psiquiátricas.
Descritores: Cortisol; Fatores de risco; Psicopatologia; Maus-tratos infantis; Hipotálamo
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Introduction
For many years, empirical observations deriving from 
psychoanalytic, psychotherapeutic and general psychiatric clinical 
settings have suggested that childhood maltreatment has long-term 
consequences on mental health in adulthood.1-3 Recently, more 
methodologically rigorous clinical and epidemiological studies 
have confirmed these earlier findings, while advances in basic and 
applied neurosciences have led to greater insights into possible 
mechanisms of pathogenesis.
Psychiatric consequences of childhood maltreatment
Childhood maltreatment is a major social problem. It is common 
and can result in serious physical injury or even death. Moreover, 
its psychological consequences can acutely affect a child’s mental 
health well into adulthood.4 Four types of maltreatment are 
commonly recognized: physical abuse, sexual abuse, emotional 
(or psychological) abuse and neglect. 
Childhood maltreatment is associated with a diverse range of 
psychiatric consequences. In children and adolescents, it increases 
the risk of behavioral problems, including internalizing (anxiety, 
depression) and externalizing (aggression, acting out) behavior.5-9 
Maltreated children have a moderately increased risk of depression 
in adolescence and adulthood (adjusted odds ratios ranging from 
1.3 to 2.4), which will partly mirror the family context in which the 
maltreatment occured.5,7,8,10-13
Because depression is common, about a quarter to a third of 
maltreated children will meet the criteria for major depression by 
their late 20’s,8,14,15 thus representing a substantial public health 
burden. For many of the affected individuals, the onset of depression 
begins in childhood, hence the importance of focusing on early 
intervention before the symptoms of depression appear in the 
abused and neglected children. Depression is commonly associated 
with neglect and physical and sexual abuse, with no clear evidence 
of more specific effects of any particular type of maltreatment. 
Some investigators have shown a dose-response relationship, with 
depression more likely occurring with harsh or severe physical abuse 
than with less severe forms of maltreatment.8,16 Consistent evidence 
suggests that both physical and sexual abuse are associated with a 
doubling of the risk of attempted suicide in young people who are 
followed up on into their late 20’s. For physical and sexual abuse, 
these effects persist after adjustment for confounding family and 
individual variables8,17 but, for neglect, these effects are mainly 
explained by family context.11
Other psychiatric disorders in adulthood that are frequently 
associated with childhood maltreatment include personality 
disorders,18,19 alcohol abuse and dependence,11 eating disorders,20 
anxiety disorders,21 and posttraumatic stress disorder (PTSD).22
Neurobiological consequences of stress
The term stress has been widely used to denote an individual’s 
response to environmental or psychosocial conditions which require 
change. Allostasis and allostatic load are more useful concepts for 
understanding the neurobiological consequences of stress. Allostasis 
involves the maintenance of stability (i.e., of homeostasis). The 
concept of allostatic load was proposed to refer to the physiological 
degradation of the individual as a result of repeated cycles of 
allostasis, as well as to the inefficient turning-on or shutting-off of 
responses to stressors.23,24 The concepts of allostasis and allostatic 
load invoke a cascade of cause and effect that begins with primary 
stress mediators, such as catecholamines and cortisol, and leads to 
primary effects and then to secondary and tertiary outcomes.
The brain acts as an integrative center coordinating the behavioral, 
neuroendocrine and other neurobiological responses of the individual 
to environmental challenges and internal physiological needs (e.g., 
thirst, hunger, sleep-wake cycle). There are considerable individual 
differences in coping with such challenges based upon interacting 
genetic, developmental and experiential factors. Moreover, there can be 
an amplifying effect of genetic predisposition and early developmental 
events, such as childhood maltreatment, thus predisposing certain 
individuals throughout their lives to over-react physiologically and 
behaviorally to events. The capacity to adapt and maintain homeostasis 
(i.e., allostasis) in the face of challenges and the ability to turn adaptive 
responses on and off efficiently are vital to survival; at the same time, 
excessive demand for such adaptive responses can lead to cumulative 
effects over long time intervals.23,24
These cumulative effects, i.e., the allostatic load caused by 
forced adaptations to various psychosocial challenges and adverse 
environments are manifested as a structural and functional 
deterioration of the organism. Among the many factors that 
contribute to allostatic load are genes, early experiences and early 
development, as well as learned behaviors reflecting life-style 
choices with respect to diet, exercise, smoking, and drinking. All 
these factors influence the reactivity of the systems that produce 
the physiological stress mediators. As a result, allostatic load 
partially reflects comes to reflect a genetically or developmentally-
programmed inefficiency in handling not only unusual stressors, but 
also the normal challenges of daily life (e.g., thirst, hunger, need 
for sleep), as well as the adverse physiological consequences of an 
unhealthy diet, sedentariness, excessive alcohol or smoking.23,24
The HPA axis and psychopathology
Hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis in 
major depression is suggested by a large body of research, including 
basal and provoked measurements of plasma HPA axis hormone 
concentrations, imaging of pituitary and adrenal gland volume, 
cerebrospinal fluid (CSF) levels of corticotrophin releasing hormone 
(CRH), and post-mortem measures of brain CRH receptor binding 
and CRH messenger ribonucleic acid (mRNA) levels.25,26 Indeed, 
hyperactivity of the HPA axis as a state marker for major depression is 
one of the most prominent findings in psychoneuroendocrinology.27-
29 Hyperactive CRH neurons, manifested as CRH hypersecretion 
and impaired efficacy of the glucocorticoid-mediated feedback are 
considered to be reliable hallmarks of the disturbed neuroendocrine 
regulation associated with, and perhaps causally related to 
depressive disorders.30
Allostatic load leads to alterations in hippocampal neuroplasticity, 
which is partially regulated by the brain-derived neurotrophic 
factor (BDNF). Hippocampal neurons subjected to an increased 
allostatic load show reductions in dendritic arborization and in BDNF 
expression, which could be one of the factors mediating the dendritic 
effects. The reduction in BDNF is partly mediated by excessive 
glucocorticoids, a characteristic feature of HPA axis hyperactivity, 
which can interfere with the normal transcriptional mechanisms that 
control BDNF expression. Decreased neurogenesis and increased 
rate of neuronal death and atrophy are also mediated by excessive 
glucocorticoids.31 Clinical studies are consistent with these findings: 
depressed patients have a significant reduction in gray matter in the 
hippocampus, anterior cingulate cortex and dorsomedial prefrontal 
cortex compared to controls. The reduction is more pronounced in 
unremitted patients than in remitted patients.32
However, the relationship between HPA function and emotional 
disturbances involving mood and anxiety is not entirely unambiguous. 
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For example, decreased, rather than increased, cortisol secretion 
has been reported in patients with nonpsychotic forms of major 
depression,33 major depression with comorbid PTSD,34 and atypical 
depression.35 Super-suppression of cortisol in response to a low-dose 
of dexamethasone, as observed in abused women with depression 
and comorbid PTSD, is a classical feature of PTSD.36,37
Moreover, HPA axis dysfunction is not restricted to depressive 
illness, but has been linked to several other psychiatric and 
functional somatic disorders. A key question is whether such 
dysfunction operates as a pre-existing pathogenic risk factor, whether 
it reflects the ongoing pathogenesis of the illness, or whether it 
represents some combination of both. 
HPA axis function in individuals with a history of childhood 
maltreatment 
1. Studies on the pituitary–adrenal and autonomic responses 
to psychosocial stress
A number of studies have used structured laboratory test settings 
to evaluate responses to psychosocial stress. Among the most widely 
employed is the Trier Social Stress Test (TSST), which consists of a 
public speaking task and a mental arithmetic task, both standardized 
and conducted in front of a panel of judges. The TSST has been 
shown to reliably induce HPA axis and sympathetic activation.38 
Blood and/or saliva samples for the determination of plasma or 
salivary adrenocorticotropin (ACTH) and cortisol levels, as well 
as heart rate measures are obtained before, during, and after the 
stress induction.
In an important study, Heim et al. used the TSST to evaluate 
neuroendocrine and autonomic responses in four groups of women 
who had been carefully categorized according to the presence or 
absence of early-life abuse and current major depression, as follows: 
1) with a history of early-life abuse and with current major depression; 
2) with a history of early-life abuse and without current major 
depression; 3) without a history of early-life abuse and with current 
major depression; and 4) without a history of early-life abuse and 
without a history of psychiatric disorder (i.e., healthy controls).39 
Women with a history of childhood abuse, with or without current 
major depression, exhibited increased ACTH responses to stress 
compared with controls. The net ACTH response was more than 
6-fold greater in abused women with current major depression than 
in controls. These women also demonstrated increased cortisol and 
heart rate responses to psychosocial stress. Abused women who 
were not currently depressed exhibited normal cortisol responses, 
despite their increased ACTH response, perhaps suggesting adrenal 
adaptation to central sensitization as a marker of resilience against 
depression after early stress. Depressed women without a history 
of abuse demonstrated normal neuroendocrine responses. 
These findings, which are consistent with studies of early-life stress 
in laboratory animals, suggest that HPA axis and autonomic nervous 
system hyperreactivity, presumably due to CRH hypersecretion, may 
be a long-lasting consequence of childhood abuse in women and 
one which may constitute a risk factor for adult psychopathology.27 
Analyzing the same data using multiple regression techniques, 
Heim et al. showed that childhood maltreatment was the strongest 
predictor of ACTH responsiveness, followed by a number of abuse 
events, adulthood traumas and depression.40 These findings indicate 
that a history of childhood abuse per se in women is related to 
increased HPA axis reactivity, which is further enhanced when 
additional trauma occurs in adulthood.27
In contrast, a more recent study by Carpenter et al. found that 
men and women with a history of childhood maltreatment and no 
history of depression had decreased cortisol responses to the TSST.41 
These findings are consistent with other recent studies showing 
attenuated cortisol responses to psychosocial or neurobiological 
challenge in adults with a history of maltreatment, as discussed 
further below.  
2. Studies on the pituitary–adrenal and autonomic responses 
to pharmacological provocation tests
The CRH and ACTH stimulation tests, derived from classical 
neuroendocrinology, have also been used to explore HPA axis 
dysfunction related to psychopathology and associated risks factors. 
The former evaluates the responsiveness of the anterior pituitary 
to CRH, with diminished reactivity presumably reflecting down-
regulation of corticothrophs in response to chronically increased 
stimulation by the CRH-containing parvocellular neurons originating 
in the paraventricular nucleus (PVN) of the hypothalamic median 
eminence.42 The latter evaluates the responsiveness of the adrenal 
cortex to its major stimulating hormone, i.e., ACTH.43
In their study of depressed and non-depressed women with and 
without a history of childhood maltreatment, Heim et al. administered 
both tests to the same subjects.42,44 They found that abused women 
without depression exhibited increased ACTH responses to CRH, 
but both groups of depressed women (with and without childhood 
maltreatment) exhibited a blunted ACTH response to CRH, which 
is consistent with many previous studies of major depression.45,46 
Abused women without depression had a lower cortisol response 
than other groups after the ACTH stimulation test.42 Laboratory 
studies on early-life stress using non-human primate models have 
demonstrated similar results.47,48
Heim et al. hypothesized that their results could reflect both a 
sensitization of the pituitary and a counter-regulatory adaptation of 
the adrenal gland in abused women without current depression. As 
cortisol has inhibitory effects on the central CRH and noradrenergic 
systems, a relative decreased availability of cortisol, as a consequence 
of childhood trauma, might facilitate disinhibition of central stress 
responses. When subjected to even more stress, such women might 
then repeatedly hypersecrete CRH, eventually resulting in pituitary 
CRH receptor downregulation and symptoms of depression through 
CRH effects in extra-hypothalamic circuits.27
However, caution is required when interpreting such findings, 
as underscored by Carpenter et al., who used multiple regression 
analysis in an effort to disentangle the effects of depression and early-
life stress on CSF CRH in adults.49 In their study of depressed and 
healthy control adults, perceived early-life stress was significantly 
correlated with concentrations of CSF CRH, but the presence of 
depression was not. However, the relationship between CSF CRH 
and early-life stress was complex: CSF CRH concentrations were 
negatively correlated (i.e., lower) with adversity in the perinatal 
and pre-teen years (ages 6-13 years), but positively correlated (i.e., 
higher) with stress in the pre-school years (ages 0-5 years). These 
findings were interpreted in light of considerable preclinical research 
in laboratory animals, demonstrating that timing of exposure to 
stressors in early life is critically important in determining their 
long-term effects on neurobiology and behavior.
3. Studies on glucocorticoid receptor (GR) sensitivity using 
pharmacological provocation tests
Basal hypocortisolism and hypersuppresion of cortisol after low 
doses of dexamethasone have been observed both in patients with 
PTSD and in women with a history of early-life stress and PTSD.36,50 
These findings are believed to reflect increased GR sensitivity. The 
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combined dexamethasone/CRH (Dex/CRH) test was developed to 
allow for a more rigorous in vivo examination of GR function by 
increasing the sensitivity of the classical dexamethasone suppression 
test (DST).51 In the Dex/CRH test, CRH-induced escape of cortisol 
from suppression reflects impaired glucocorticoid-mediated feedback 
control of the HPA axis under conditions of increased hypothalamic 
drive.
Heim et al. used this approach to study HPA axis function in 
men with and without major depression and childhood abuse.52 
Abused men demonstrated increased cortisol responses compared 
to non-abused men, regardless of the presence of major depression. 
Increased responses were associated with exposure to both sexual 
and physical abuse, and were correlated with the severity of abuse. 
Their results suggested that childhood maltreatment is associated 
with impaired glucocorticoid-mediated feedback control of the HPA 
axis under stimulated conditions.
Similar results have been reported for women with borderline 
personality disorder. Rinne et al. compared borderline personality 
disorder patients with and without sustained childhood abuse and 
comorbid PTSD or major depression with healthy control subjects.53 
The borderline patients who had been chronically abused had 
increased ACTH and cortisol responses to the Dex/CRH test; the 
presence of comorbid PTSD significantly attenuated the ACTH 
response. 
Once again, however, specific factors relating to the nature of the 
abuse can markedly affect the results of such studies. Carpenter 
et al. recently reported their findings with the Dex/CRH test in 
a large sample of 230 adults without major Axis I disorders.54 
Using a general linear models analysis, the authors tested for a 
large number of potentially confounding variables, including age, 
gender, education level, socioeconomic adversity in childhood, 
current depressive and anxiety symptoms, smoking, exogenous 
hormone use (for contraception or estrogen replacement) and types 
of maltreatment. They found that a history of self-reported childhood 
emotional abuse was independently and significantly associated 
with diminished cortisol response to the Dex/CRH test, whereas 
physical abuse, sexual abuse, emotional neglect and physical 
neglect had no significant independent effects.
Currently available studies indicate that much still remains to be 
learned about the different clinical factors that affect GR function 
in humans and how this process takes places. At the same time, 
recent preclinical research has shown, more clearly than ever, 
how GR function could be implicated in the pathogenesis of HPA 
axis dysfunction in clinical settings. For example, early adversity in 
rodents induces reduced expression of GR’s at the epigenomic level 
by inducing DNA methylation at a promoter site of the GR gene.55,56 
It would be logical to expect that the impaired glucocorticoid effects 
resulting from this may contribute to increased stress reactivity and 
promote symptoms of depression.57
Long-term sequelae of early-life stress: moderating and 
mediating factors 
As is evident from the preceding discussion, the ultimate effects 
of childhood maltreatment in terms of HPA axis function and 
psychiatric outcome in adulthood reflect a complex interplay of other 
moderating and mediating conditions. Elucidation of these factors 
and the nature of their relationships with adulthood outcomes is a 
major challenge. 
For example, clinical experience and the preclinical animal 
literature suggest that early developmental events can have a major 
impact on subsequent psychological and neurobiological function. 
We recently studied 42 premature infants born at 33.3±1.9 weeks 
gestation of whom 15 were maintained in incubators for least 2 
weeks and 27 were cared for with the kangaroo method, in which 
infant and mother consistently maintain skin-to-skin contact using 
specially-applied bandages (Mello et al., unpublished data). Groups 
did not differ with respect to gender, socioeconomic status, birth 
weight, gestational age or age at evaluation. We hypothesized 
that incubator care could serve as a naturalistic human model of 
maternal deprivation. Regression analysis showed that, at the age 
6 months, infants who had been placed under incubator care/who 
had received care through an incubator had higher awakening 
salivary cortisol concentrations and were shorter compared to 
those receiving the kangaroo method. There were no differences in 
weight or cognitive and psychomotor development. These results 
are consistent with studies in laboratory animals showing that 
experimental early maternal deprivation increases HPA axis activity, 
which could in turn be a risk factor for psychiatric illness. 
Similarly, late life events in an individual’s personal history can also 
promote risk or resilience to the development of psychopathology. 
Tyrka et al., while studying ACTH and cortisol responses to the 
Dex/CRH test in healthy adults with or without a history of parental 
loss found that the former group had increased cortisol responses, 
an effect that was particularly robust in men.58 However, levels of 
parental care moderated the effect of loss: subjects with parental 
desertion and very low levels of care had attenuated cortisol 
responses. ACTH responses did not differ between groups. 
Finally, it should be noted that moderating and mediating factors 
need not only be extrinsic events in an individual’s history as they 
can also be intrinsic. Tyrka et al. used the TSST and the Dex/CRH 
test to evaluate the effects of temperament on HPA axis in healthy 
adults without significant psychopathology.59,60 They found that 
in both psychosocial stress and pharmacological challenge tests, 
those with inhibited temperament (low novelty-seeking behavior) 
had higher cortisol responses compared to those with high novelty-
seeking behavior. 
The HPA axis and genetics 
If HPA axis function can be affected by an individual characteristic 
such as temperament, which is, in itself, complexly reflective of 
both constitutional and early experiential factors, it should be 
obvious that genetic influences on the HPA axis are likely to be 
significant. Empirical demonstrations of such influences in humans 
have begun to appear. For example, Baghai et al. demonstrated 
that the angiotensin converting enzyme (ACE) insertion/deletion 
polymorphism significantly altered the cortisol response to the 
Dex/CRH test in patients with major depression, with insertion 
homozygotes showing higher cortisol responses than deletion 
homozygotes; differences were no longer evident after successful 
antidepressant treatment.61 Similarly, Wust et al. showed that 
glucocorticoid receptor gene polymorphisms determined the 
cortisol response to both provocative pharmacological testing and 
psychosocial stress, as measured by the TSST.62 
Genetics and the long-term sequelae of early-life stress
Contemporary work on the interaction of genetics and stress 
has been profoundly influenced by the findings of Caspi et al., 
who studied a functional polymorphism in the promoter region 
of the serotonin transporter gene (5-HTTLPR) in a sample of 
847 children who were followed prospectively from ages 3 to 26 
years.63 Individuals with one or two copies of the short allele of the 
polymorphism were more likely to develop depression and related 
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symptoms in response to stressful life events than were individuals 
who were homozygous for the long allele. This study has been one 
of the most convincing empirical demonstrations to date of the 
gene-environment interaction in the pathogenesis of psychiatric 
illness. Kaufman et al. extended these findings to maltreated 
children, showing that low social support and the short allele of 
the 5-HTTLPR polymorphism interact with each other to incur in 
the greatest risk for depression.64 
Barr et al. addressed the interaction of genetics and early-life 
stress in modulating HPA axis function in a study of ACTH and 
cortisol responses to stress in rhesus macaque monkeys.65 They 
found that the genotype of the rh5-HTTLPR polymorphism (which 
is orthologous with the 5-HTTLPR polymorphism in humans) and 
rearing condition independently influenced HPA axis responses 
to stress. Moreover, rearing, rh5-HTTLPR genotype and sex 
interacted with one another: adverse rearing conditions and the 
rh5-HTTLPR short allele resulted in lower cortisol responses to 
stress in females, but not in males. More recently, Bradley et al. 
have extended this work to genes that directly control HPA axis 
function, demonstrating that reported childhood abuse interacts with 
single nucleotide polymorphisms (SNPs) in the CRH Type I receptor 
gene, thus allowing for the prediction of depressive symptoms in 
adulthood.66  
Exciting preclinical studies have begun to elucidate the molecular 
basis of such findings, showing that environmental factors are 
actually capable of altering gene expression. This reflects recent 
advances in the field of epigenetics, the study of how differences 
in phenotype and gene expression can be caused by changes in 
chromosome or chromatin packaging (as opposed to by changes 
in the DNA sequence). There is emerging evidence that such 
changes can remain stable between cell divisions, and might show 
transgenerational inheritance. 
In their review of the role of epigenetics in psychiatric disorders, 
Tsankova et al. illustrated the significance of such findings by 
providing the example of BDNF. This protein has been extensively 
implicated in the pathophysiology of depression and the mechanism 
of action of antidepressant treatments, and recent work has focused 
on the regulation of its gene, bdnf.67 Studies using an animal model 
of depression (chronic defeat) have shown that, in a controlled 
environment with no stress, bdnf chromatin demonstrates moderate 
histone H3 acetylation and no histone H3-K27 dimethylation. In 
this state, histone deacetylase 5 (HDAC5) represses unnecessary 
activation of BDNF and maintains chromatin balance. The stress 
of chronic defeat induces the dimethylation of histone H3-K27, 
resulting in a “closed” chromatin state at bdnf promoters and 
repression of bdnf transcript expression. Imipramine treatment after 
defeat stress down-regulates Hdac5 gene expression and increases 
H3 acetylation, “reopening” the repressed chromatin state and 
reactivating transcriptional activity of the bdnf gene. In other words, 
an experiential factor (chronic defeat stress) alters BDNF function 
by physically modifying its gene, an effect which can, in turn, be 
reversed by antidepressant treatment.
 
Determinants of HPA axis function following early-life stress
To do a review, it is essential to recognize that, although 
the effects of early-life stress on the HPA axis are now well 
documented, such effects cannot be thought of in simplistic 
or bivariate terms. Rather, the understanding of these effects 
requires that a broad range of factors that can exert their influence 
via the stressor, the HPA axis, or the interaction of the two be 
systematically considered. 
For example, above, we have considered evidence that timing of 
the stressor may be of importance, where attenuated HPA function 
appears following preschool stressors and enhanced function 
following preteen stress.68,69 The nature of the stressor is relevant, 
with some studies suggesting increased HPA reactivity following 
early-life physical or sexual abuse or parental loss, but diminished 
reactivity following emotional abuse. At the same time, these 
effects can be moderated or mediated by other factors such as 
parental desertion or neglectful care (decreasing reactivity), inhibited 
temperament (increasing reactivity) or advancing age (decreasing 
reactivity). Comorbid psychiatric conditions, recent stressors, and 
genetic vulnerability also clearly impact HPA axis responsivity.
These factors are all, of course, extrinsic to the HPA axis itself. 
Divergent findings across and even within studies have underscored 
the fact that the way in which the “HPA axis function” is evaluated 
depends on which specific parameters are assessed. Such 
parameters include the tissue being assayed (e.g., brain, CSF, blood, 
saliva, lymphocytes), the biochemical substance being measured 
(e.g., mRNA, receptors, CRH, ACTH, cortisol), the experimental 
method employed (e.g., basal vs. provocative [e.g., TSST, Dex/
CRH]), and the index used for analysis (e.g., peak change, recovery, 
area-under-the-curve [AUC]). 
Conclusion 
Risk for adult psychopathology is related to a complex 
interaction of multiple experiential factors: prenatal, perinatal, past 
environmental, and current environmental. Specific genes confer 
susceptibility to certain kinds of experiential factors that can lead 
to or modulate HPA axis dysfunction and psychopathological/
psychopathology risk. HPA axis response to stress can be thought 
of as a mirror of the organism’s response to stress: acute responses 
are generally adaptive, but excessive or prolonged responses 
can lead to deleterious effects. These deleterious effects, which 
may not be clinically obvious, have the potential to serve as 
endophenotypic markers of susceptibility to disease. Early-life stress 
in rodents, nonhuman primates and humans (including childhood 
maltreatment) alters HPA axis function and behavior, but the specific 
pattern of HPA dysfunction and probably the nature of the adult 
psychopathology are reflective of both the characteristics of the 
stressor and an array of modifying factors.
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